A 35-year-old woman with systemic lupus erythematosus (SLE) on prednisolone 20 mg daily for 6 months presents with polyuria, polydipsia, and a fasting blood glucose of 180 mg/dL. Her HbA1c is 8.2%. She has no prior history of diabetes. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has developed **steroid-induced hyperglycemia** (new-onset hyperglycemia attributable to corticosteroid use) while on a relatively high dose of prednisolone for SLE management. The HbA1c of 8.2% indicates sustained hyperglycemia over weeks. ## Pathophysiology of Steroid-Induced Hyperglycemia Corticosteroids cause hyperglycemia through multiple mechanisms: 1. Increased hepatic gluconeogenesis (via increased substrate availability and enzyme expression) 2. Decreased peripheral glucose utilization (insulin resistance) 3. Impaired pancreatic β-cell insulin secretion 4. Increased lipolysis and free fatty acid availability ## Management Strategy **Key Point:** The cornerstone of managing steroid-induced hyperglycemia is **dose reduction or tapering** of the corticosteroid whenever clinically feasible, combined with glycemic monitoring. **High-Yield:** Steroid-induced hyperglycemia often resolves or improves significantly after tapering the corticosteroid dose. Insulin is preferred over oral agents during high-dose steroid therapy because it provides more predictable glycemic control and can be rapidly titrated. ### Rationale for Correct Answer Gradual tapering of prednisolone is the most appropriate next step because: - It addresses the **root cause** (excessive corticosteroid dose) rather than merely treating the symptom - SLE often allows dose reduction after initial disease control is achieved - Hyperglycemia frequently resolves or improves after tapering - If hyperglycemia persists after tapering, insulin can be initiated at that point - This approach minimizes long-term medication burden **Clinical Pearl:** In steroid-induced hyperglycemia, the glucose elevation is typically **dose-dependent**. Reducing the steroid dose often leads to proportional improvement in glycemic control without requiring permanent antidiabetic therapy. ## Why Tapering + Insulin (if needed) Is Superior to Alternatives | Approach | Advantage | Disadvantage | |----------|-----------|-------------| | **Taper + insulin if persistent** | Addresses root cause; insulin provides tight control during high-dose steroid phase | Requires monitoring | | Continue same dose + metformin | Avoids tapering | Does not address root cause; metformin less effective during high-dose steroid use | | Switch to dexamethasone | Dexamethasone has longer half-life | Does not reduce hyperglycemia risk; dexamethasone is more potent and more diabetogenic | | Discontinue prednisolone | Eliminates steroid effect | Risks SLE flare; not appropriate when SLE is active | ## Monitoring Plan During Tapering **Key Point:** Fasting and random blood glucose should be monitored weekly during tapering. Insulin dose (if initiated) should be reduced proportionally as prednisolone is tapered.